Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology News Journal.
Press releases published on September 4, 2025
Computer Modelling Group Announces Voting Results of Election of Directors and New Board Chair
GlobeNewswire
·
September 4, 2025
CALGARY, Alberta, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Computer Modelling Group Ltd. (“CMG” or the “Company”) announces that, at its annual meeting of shareholders held earlier today, all the nominees listed in its Management Information Circular dated July …
Orchestra BioMed Presents New AVIM Therapy Clinical Data at HRX Demonstrating Substantial and Sustained Blood Pressure Reductions that are Reproducible Upon Reactivation Following Washout
GlobeNewswire
·
September 4, 2025
Results from long-term follow up of patients treated with atrioventricular interval modulation (“AVIM”) therapy show blood pressure-lowering effects are sustained for years after activation, reversible with no observed rebound hypertension upon …
Bocana Resources Corp. Reports on the Recent Site Visit to the Arizona Mining Claims
GlobeNewswire
·
September 4, 2025
CALGARY, Alberta, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bocana Resources Corp. (TSXV: BOCA) (Frankfurt: VC1) ("Bocana" or the "Company"), further to the press release dated August 11, 2025 and August 18, 2025, in connection with the due diligence efforts of …
Kadant Declares Cash Dividend
GlobeNewswire
·
September 4, 2025
WESTFORD, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE: KAI) announced today that its Board of Directors has approved a quarterly cash dividend to stockholders of $0.34 per share to be paid on November 6, 2025 to stockholders of record as of …
ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 4, 2025
SAN DIEGO, Sept. 04, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on …
Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 4, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye …
Microchip Technology to Present at the Goldman Sachs Communacopia + Technology Conference
GlobeNewswire
·
September 4, 2025
CHANDLER, Arizona, Sept. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today announced that the Company will present at the Goldman Sach …
Coherent Debuts 30kW EDGE FL Fiber Laser for Thick Sheet Cutting at FABTECH Chicago
GlobeNewswire
·
September 4, 2025
SAXONBURG, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced the debut of its EDGE FL30 fiber laser, a groundbreaking 30 kW laser source engineered to deliver unmatched performance in metal …
NBME celebrates 110th anniversary of advancing assessment in medical education
GlobeNewswire
·
September 4, 2025
PHILADELPHIA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- This year, NBME celebrates 110 years of creating high-quality assessments for medical learners. As a not-for-profit organization, NBME aims to advance assessment of health care professionals to achieve …
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference
GlobeNewswire
·
September 4, 2025
CHASKA, Minn., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 24th Annual …
ServiceTitan Announces Strategic Partnership With Roto-Rooter
GlobeNewswire
·
September 4, 2025
LOS ANGELES, Sept. 04, 2025 (GLOBE NEWSWIRE) -- ServiceTitan (Nasdaq: TTAN), the software platform that powers the trades, today announced a strategic partnership with Roto-Rooter, the largest provider of plumbing, drain cleaning, and water cleanup …
ServiceTitan Announces Fiscal Second Quarter Financial Results
GlobeNewswire
·
September 4, 2025
LOS ANGELES, Sept. 04, 2025 (GLOBE NEWSWIRE) -- ServiceTitan (NASDAQ: TTAN), the software platform that powers the trades, today announced financial results for the fiscal second quarter ended July 31, 2025. “I am grateful for the way our team empowered …
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 4, 2025
CONSHOHOCKEN, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it …
Regeneron Announces Updated Presentation Time for Upcoming Investor Conference
GlobeNewswire
·
September 4, 2025
TARRYTOWN, N.Y., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will now present at the Morgan Stanley 23rd Annual Global Healthcare Conference at 7:00 a.m. ET on Monday, September 8, 2025. The …
Service Coordination, Inc. President & CEO John Dumas Named One of Maryland’s 2025 Most Admired CEOs
GlobeNewswire
·
September 4, 2025
Frederick, MD, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Daily Record has named John Dumas, President …
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
GlobeNewswire
·
September 4, 2025
Another addition to Amneal’s growing complex injectables portfolio reflects leadership in advanced development and manufacturing of complex pharmaceuticals BRIDGEWATER, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the …
Mineralys Therapeutics Announces Closing of Upsized $287.5 Million Underwritten Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
September 4, 2025
RADNOR, Pa., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), …
Praxis Precision Medicines to Participate in September Investor Conferences
GlobeNewswire
·
September 4, 2025
BOSTON, Mass., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders …
Inventiva to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
September 4, 2025
Daix (France), New York City (New York, United States), September 4, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment …
Inventiva annonce sa participation à plusieurs conférences investisseurs en septembre
GlobeNewswire
·
September 4, 2025
Daix (France), New York City (New York, Etats-Unis), le 4 septembre 2025 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement de thérapies orales pour le traitement de …